Treatment of Guillain-Barré Syndrome

Autor(es): Nomura Kyoichi

Resumo: The treatment of Guillain-Barre syndromé (GBS) was mainly symptomatic until the 1950s, followed by corticosteroid treatment in the 1950s through 1960s. Plasma exchange (PE) was then performed during 1970s through the 1980s, after which intravenous immunoglobulin (IVIg) was performed in 1990s through the 2000s. The effectiveness of IVIg and PE has been established by randomized controlled trial(RCT). Recently, new treatments using biological products have been explored. In this paper, we summarize the development of the treatment of GBS.

Imprenta: Brain and Nerve = Shinkei Kenkyu? no Shinpo, v. 67, n. 11, p. 1397-1410, 2015

Identificador do objeto digital: 10.11477/mf.1416200312.

Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies

Data de publicação: 2015